Abstract
Acute kidney injury (AKI) is often overlooked in hospitalized patients, despite the fact that even mild forms are strongly associated with poor clinical outcomes such as increased mortality, morbidity, cardiovascular failure and infections. Research endorsed by the Acute Dialysis Quality Initiative led to the publication of a consensus definition for AKI—the RIFLE criteria (Risk, Injury, Failure, Loss of function, and End-stage renal disease)—which was designed to standardize and classify renal dysfunction. These criteria, along with revised versions developed by the AKI Network (AKIN), can detect AKI with high sensitivity and high specificity and describe different severity levels that aim to predict the prognosis of affected patients. The RIFLE and AKIN criteria are easy to use in a variety of clinical and research settings, but have several limitations: both utilize an increase in serum creatinine level from a hypothetical baseline value and a decrease in urine output, but these surrogate markers of renal impairment manifest relatively late after injury has occurred and do not consider the nature or site of the kidney injury. New biomarkers for AKI have shown promise for early diagnosis and prediction of the prognosis of AKI. As more data become available, they could, in the future, be incorporated into improved definitions or criteria for AKI.
Key Points
-
A widely accepted definition of and classification criteria for acute kidney injury (AKI) is one of the most important acquisitions for research into AKI epidemiology, prevention and management
-
A consensus definition of AKI should be simple to apply in clinical and research settings, highly sensitive and specific, represent the spectrum of disease severity, and correlate well with outcome
-
The RIFLE and AKIN criteria enable the reliable clinical diagnosis of AKI and indicate a direct relationship between the severity of AKI and patients outcome
-
The RIFLE and AKIN criteria have limitations, and further refinements that can provide a definitive classification are anticipated in the near future
-
Tests for neutrophil gelatinase-associated lipocalin and cystatin C are widely available; these biomarkers exhibit optimal qualities to predict the occurrence and prognosis of AKI
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hoste, E. A. & Kellum, J. A. Acute kidney injury: epidemiology and diagnostic criteria. Curr. Opin. Crit. Care 12, 531–537 (2006).
Uchino, S., Bellomo, R., Bagshaw, S. M. & Goldsmith, D. Transient azotaemia is associated with a high risk of death in hospitalized patients. Nephrol. Dial. Transplant. 25, 1833–1839 (2010).
Mehta, R. L. et al. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int. 66, 1613–1621 (2004).
Ricci, Z. et al. Practice patterns in the management of acute renal failure in the critically ill patient: an international survey. Nephrol. Dial. Transplant. 21, 690–696 (2006).
Basso, F., Ricci, Z., Cruz, D. & Ronco, C. International survey on the management of acute kidney injury in critically ill patients: year 2007. Blood Purif. 30, 214–220 (2010).
Bellomo, R. et al. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit. Care 8, R204–R212 (2004).
Ricci, Z., Cruz, D. N. & Ronco, C. The RIFLE criteria and mortality in acute kidney injury: a systematic review. Kidney Int. 73, 538–546 (2008).
Bagshaw, S. M., Gibney, R. T., McAlister, F. A. & Bellomo, R. The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury. Trials 11, 50 (2010).
Lentini, P. et al. The role of advanced oxidation protein products in intensive care unit patients with acute kidney injury. J. Crit. Care 25, 605–609 (2010).
Akcan-Arikan, A. et al. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int. 71, 1028–1035 (2007).
Cruz, D. N., Ricci, Z. & Ronco, C. Clinical review: RIFLE and AKIN—time for reappraisal. Crit. Care 13, 211 (2009).
Gaiao, S. & Cruz, D. N. Baseline creatinine to define acute kidney injury: is there any consensus? Nephrol. Dial. Transplant. 25, 3812–3814 (2010).
Lassnigg, A. et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J. Am. Soc. Nephrol. 15, 1597–1605 (2004).
Bernard, G. R. et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med. 149, 818–824 (1994).
Mehta, R. L. et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit. Care 11, R31 (2007).
Ricci, Z. & Ronco, C. Year in review 2007: critical care—nephrology. Crit. Care 12, 230 (2008).
Joannidis, M. et al. Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med. 35, 1692–1702 (2009).
Bagshaw, S. M. Acute kidney injury: diagnosis and classification of AKI: AKIN or RIFLE? Nat. Rev. Nephrol. 6, 71–73 (2010).
Hsu, C. Y. et al. Community-based incidence of acute renal failure. Kidney Int. 72, 208–212 (2007).
Nash, K., Hafeez, A. & Hou, S. Hospital-acquired renal insufficiency. Am. J. Kidney Dis. 39, 930–936 (2002).
Bagshaw, S. M., George, C. & Bellomo, R. A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol. Dial. Transplant. 23, 1569–1574 (2008).
Uchino, S., Bellomo, R., Goldsmith, D., Bates, S. & Ronco, C. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit. Care Med. 34, 1913–1917 (2006).
Bagshaw, S. M. et al. A comparison of observed versus estimated baseline creatinine for determination of RIFLE class in patients with acute kidney injury. Nephrol. Dial. Transplant. 24, 2739–2744 (2009).
Siew, E. D. et al. Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury. Kidney Int. 77, 536–542 (2010).
Závada, J. et al. A comparison of three methods to estimate baseline creatinine for RIFLE classification. Nephrol. Dial. Transplant. 25, 3911–3918 (2010).
Zappitelli, M. et al. Ascertainment and epidemiology of acute kidney injury varies with definition interpretation. Clin. J. Am. Soc. Nephrol. 3, 948–954 (2008).
Schwartz, G. J., Haycock, G. B., Edelmann, C. M. Jr & Spitzer, A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58, 259–263 (1976).
Hoste, E. A. et al. The epidemiology of cardiac surgery-associated acute kidney injury. Int. J. Artif. Organs 31, 158–165 (2008).
Macedo, E. et al. Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients. Crit. Care 14, R82 (2010).
Haase, M. et al. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am. J. Kidney Dis. 54, 1012–1024 (2009).
Cruz, D. N. et al. Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med. 36, 444–451 (2010).
Siew, E. D. et al. Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults. J. Am. Soc. Nephrol. 20, 1823–1832 (2009).
Zappitelli, M. et al. Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study. Crit. Care 11, R84 (2007).
Washburn, K. K. et al. Urinary interleukin-18 is an acute kidney injury biomarker in critically illchildren. Nephrol. Dial. Transplant. 23, 566–572 (2008).
Herget-Rosenthal, S. et al. Early detection of acute renal failure by serum cystatin C. Kidney Int. 66, 1115–1122 (2004).
Waikar, S. S. & Bonventre, J. V. Creatinine kinetics and the definition of acute kidney injury. J. Am. Soc. Nephrol. 20, 672–679 (2009).
Cruz, D. N. et al. Renal replacement therapy in adult critically ill patients: when to begin and when to stop. Contrib. Nephrol. 165, 263–273 (2010).
Bagshaw, S. M., Cruz, D. N., Gibney, R. T. & Ronco, C. A proposed algorithm for initiation of renal replacement therapy in adult critically ill patients. Crit. Care 13, 317 (2009).
Gibney, N. et al. Timing of initiation and discontinuation of renal replacement therapy in AKI: unanswered key questions. Clin. J. Am. Soc. Nephrol. 3, 876–880 (2008).
Haase-Fielitz, A. et al. The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury. Nephrol. Dial. Transplant. 24, 3349–3354 (2009).
Author information
Authors and Affiliations
Contributions
Z. Ricci and D. N. Cruz researched data for the article and wrote the manuscript. C. Ronco reviewed and edited the manuscript before submission, and all authors contributed to discussions of the content.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Ricci, Z., Cruz, D. & Ronco, C. Classification and staging of acute kidney injury: beyond the RIFLE and AKIN criteria. Nat Rev Nephrol 7, 201–208 (2011). https://doi.org/10.1038/nrneph.2011.14
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2011.14
This article is cited by
-
Evaluation of simple diagnostic parameters in acute kidney injury in hospitalized patients—diagnostic recommendations for non-nephrologists
Internal and Emergency Medicine (2023)
-
The comparison of albumin and 6% hydroxyethyl starches (130/0.4) in cardiac surgery: a meta-analysis of randomized controlled clinical trials
BMC Surgery (2021)
-
Recent advances in engineered nanomaterials for acute kidney injury theranostics
Nano Research (2021)
-
Risk estimation model for acute kidney injury defined by KDIGO classification after heart valve replacement surgery
General Thoracic and Cardiovascular Surgery (2020)
-
Epidemiology of acute kidney injury in intensive care units in Beijing: the multi-center BAKIT study
BMC Nephrology (2019)